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 Introduction 
 For clinical purposes, olfactory complaints can be 
 divided into quantitative (e.g. anosmia or hyposmia)
and qualitative (e.g. phantosmia or parosmia) disorders, 
whereas both can occur simultaneously in a given patient. 
In contrast to hyposmia and anosmia, which are easily as-
sessed by psychophysical and electrophysiological tests, 
parosmia and phantosmia are only diagnosed based on the 
patient’s history. Currently, no tests are available to inves-
tigate the presence of parosmia and phantosmia. Parosmia 
is the distorted olfactory perception in presence of an odor 
source, and phantosmia, or olfactory hallucination, is an 
erroneous odor occurring without any trigger. Parosmia 
is mostly associated with postinfectious and posttraumat-
ic olfactory dysfunction while phantosmia does not seem 
to be particularly related to any kind of cause of olfactory 
disorder. In most cases, phantosmia has no detectable ori-
gin and is diagnosed as idiopathic phantosmia  [1–2] . 
 Several case reports identified idiopathic phantosmia 
to herald diseases such as tumors, chronic rhinosinusitis, 
intracranial hemorrhages, epilepsy, psychiatric condi-
tions or, as recently suggested, Parkinson’s disease (PD) 
 [3] . In idiopathic hyposmia and anosmia, we could re-
cently show that almost 10% of patients develop extrapy-
ramidal symptoms or PD 4 years after initial presentation 
 [4] . In light of these recent findings, the goal of the pres-
ent study was to (1) investigate if any of the patients seen 
for idiopathic phantosmia at the Smell and Taste Clinic 
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 Abstract 
 Background/Aim: Little is known about the clinical signifi-
cance of phantosmia. The literature on phantosmia indicates 
that this symptom has a wide range of differential diagnoses. 
However, most cases of phantosmia remain of unknown ori-
gin. Our goal was to follow up patients with idiopathic phan-
tosmia, with special regard to improvement rates and pos-
sible severe health conditions preceded by phantosmia of 
unknown origin.  Methods: Forty-four patients with idio-
pathic phantosmia which had consulted our Ear-Nose-Throat 
Smell and Taste Clinic over the last 10 years were contacted 
by telephone and underwent a structured medical inter-
view.  Results: None of the patients had developed any se-
vere health condition or Parkinson’s disease. More than 5 
years after the occurrence of phantosmia, more than 50% of 
the patients experienced disappearance (31.8%) or improve-
ment (25%). In the remaining cases, phantosmia did not 
change (38.7%) or became worse ( ! 5%).  Conclusion: The 
main findings of the present study were that idiopathic 
phantosmia improves or disappears in almost two thirds of 
the patients after more than 5 years, and that idiopathic 
phantosmia seems to be more likely a harmless symptom 
rather than a reliable predictor of early Parkinson’s disease or 
other severe diseases.  Copyright © 2010 S. Karger AG, Basel 
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developed PD, other neurodegenerative disorders or any 
other severe health condition, and (2) to gain further in-




 The database of the Smell and Taste Clinic of the Otorhinolar-
yngology Department of the University Medical School of Dres-
den was searched for all cases of patients which had been diag-
nosed with ‘idiopathic phantosmia’ since 2002. A total of 58 pa-
tients could be identified. All patients had been regularly followed 
up in our Smell and Taste Outpatient Clinic, and details such as 
patient history and supplementary exams (blood samples and im-
aging) were reanalyzed in order to assure that no case was likely 
to be due to any other classical cause of olfactory disorder (e.g. 
head trauma, upper airway tract infection, or others). The results 
of the olfactory tests, which were done with the aid of the Sniffin 
Sticks at initial presentation, were also recorded. This test consists 
of 3 subtests (threshold, discrimination and identification) form-
ing a composite TDI score, which in the meantime is widely used 
in Europe for psychophysical testing of olfactory function with 
recently published and updated norm values [for details, see  5 ]. 
According to these TDI values, the patients could be divided into 
groups suffering from anosmia, hyposmia or showing normos-
mia besides phantosmia.
 Follow-Up 
 A trained neurologist and expert in PD (A.H.) contacted all 
the patients by phone and interviewed them in a structured way, 
including a detailed patient history, new medications, any kind of 
health situation changes and especially regarding the presence of 
extrapyramidal symptoms. Additionally, the patients had to ex-
plain whether the phantosmia symptoms had disappeared, im-
proved, remained unchanged or worsened since initial presenta-
tion. The study was conducted according to the Declaration of 
Helsinki on Biomedical Research Involving Human Subjects and 
approved by the institutional review board.
 Statistical Analysis 
 Results were analyzed using SPSS 15 for Windows TM (SPSS Inc., 
Chicago, Ill., USA). Descriptive statistics were presented as means 
and standard errors of the mean. One-way ANOVA was used to 
investigate differences between the mean values of phantosmia 
duration, age and TDI regarding follow-up evolution (disappear-
ance, improvement, status quo, worsening). Correlation analyses 
were performed using Spearman analyses. For other nonparamet-
ric statistics,   2 tests were used. The   level was set at 0.05.
 Results 
 Patient Characteristics 
 Of the 58 identified patients diagnosed with idiopath-
ic phantosmia, 44 patients (76%, 18 men and 26 women, 
mean age 59.3  8 3.2 years) could be contacted by phone. 
The remaining patients either changed address or could 
not be reached despite several attempts. Male and female 
patients did not differ regarding mean age (men 60.3  8 
3.5 years, women 58.3  8 2.2 years; p = 0.5), TDI score 
(men 19.1  8 1.5 points, women 19.6  8 1.7 points; p = 0.8) 
or duration of phantosmia (men 6.1  8 0.95 years, women 
6.3  8 0.7 years; p = 0.8). Fourteen patients had concom-
itant anosmia (31.8%), 26 patients had hyposmia (59.1%) 
and 4 patients were normosmic (9.1%). The mean dura-
tion of phantosmia was 6.3  8 0.9 years.
 Follow-Up 
 None of the patients had developed any extrapyrami-
dal symptoms or PD, nor did any other severe health 
problems (e.g. brain tumor) occur.
 Phantosmia symptoms disappeared in 14 patients 
(31.8%), improved in 11 patients (25%), remained the same 
in 17 patients (38.7%) and worsened in 2 patients (4.5%; 
 fig. 1 ). One-way ANOVA showed that neither TDI score
(F = 1.3, p = 0.2), duration of phantosmia (F = 0.7, p = 0.5) 
nor age (F = 0.3, p = 0.8) were associated with any of the 
following variables: disappearance, improvement, status 
quo or worsening. Frequency analysis did not show any 
factor such as gender (  2 test, F = 1.2, d.f. = 3; p = 0.7) or 
TDI score (anosmia, hyposmia, normosmia,   2 test, F = 6.9, 
d.f. = 6; p = 0.3) to be associated with phantosmia recovery. 
 Discussion 
 The main findings of the present study were (1) that 
idiopathic phantosmia improves or disappears in more 









 Fig. 1. Percentage of patients who report disappearance, improve-
ment, worsening or no change at all of phantosmia more than 5 




that idiopathic phantosmia seems to be more likely a 
harmless symptom rather than a reliable predictor of ear-
ly PD or other severe diseases, at least not for the current 
interval of observation. 
 Most clinical literature on olfactory disorders is fo-
cused on measurable dysfunction such as anosmia and 
hyposmia  [6] ; today, reliable data on the frequency, ori-
gins and spontaneous recovery rates of quantitative smell 
disorders exist  [7, 8] . The clinical knowledge of qualita-
tive olfactory disorders is a little different. Systematic in-
vestigation of when and how often parosmia occurs re-
vealed that this symptom is mostly linked to postinfec-
tious and posttraumatic olfactory disorders  [1] but also 
occurs in the healthy population, though to a much less-
er extent  [9] . Parosmia seems to be linked with lower ol-
factory bulb volumes in patients with hyposmia when 
compared with hyposmic patients without parosmia  [10] . 
Parosmia progressively and spontaneously disappears 
over a period of 1.5 years in one third of the patients  [11] 
and only recently has been identified as a positive predic-
tor for spontaneous recovery  [12] .
 The literature on phantosmia is rather sparse with less 
than 25 articles found in Pubmed when typing this key-
word. This is partly due to the fact that many synonyms 
are used for phantosmia such as olfactory hallucination, 
unstimulated olfactory distortion or dysosmia. However, 
extending the search with all these keywords still shows 
that most articles are case reports with varying etiologies 
for the described odor phantom. Besides the pioneering 
work of Leopold and colleagues  [2, 13, 14] who attempted 
to systematically describe, diagnose and treat phantos-
mia, little clinically useful knowledge is available to the 
otorhinolaryngologist. Recently, Reden et al.  [1] identi-
fied phantosmia to potentially occur in almost all condi-
tions affecting the sense of smell. Amongst investigated 
cases, idiopathic phantosmia was the most frequent diag-
nosis. 
 Very little information is available on how idiopathic 
phantosmia evolves over time. Deems et al. [15] reported 
that approximately 10% of dysosmia patients recover 
from the distortion. Unfortunately, these authors did nei-
ther differentiate between parosmia and phantosmia nor 
did they specify after what time lapse recovery occurred. 
Reden et al.  [1] reported parosmia to disappear or weaken 
in 29% and phantosmia in 53% of followed-up patients 
after an observational period of almost 1 year. This is 
similar to our rate after a mean observation of 6 years, 
which suggests that most phantom smells disappear 
within the first year, and very little supplementary recov-
ery can be expected after this period.
 Since curative treatment for olfactory disorders is not 
always possible, serious counseling concerning possible 
prognosis and evolution becomes more important  [16] . 
With the present data we hope to provide valuable prog-
nostic information when it comes to give possible out-
looks for symptom evolution to patients with phantos-
mia. In light of the fact that qualitative olfactory disor-
ders such as parosmia and phantosmia may affect the 
quality of life  [17] , it appears to be helpful for physicians 
to tell the patient that in more than half of the cases phan-
tosmia will disappear completely or improve and that 
phantosmia is not a common predictor of PD as it seems 
to be the case for unexplained hyposmia  [18] . Compared 
with parosmia, it has to be noted that the time lapse be-
tween occurrence and improvement seems to be similar, 
with phantosmia taking almost a year and parosmia 14 
months in average to improve  [1, 11] . 
 It has to be kept in mind that the present study did not 
identify gender, age or measurable olfactory function at 
initial presentation to be considered as positive or negative 
predictive factors for improvement of phantosmia. Vice 
versa, parosmia but not phantosmia has recently been 
shown to be a positive predictor of olfactory recovery  [12] . 
 In qualitative gustatory symptoms, generally sub-
sumed as dysgeusia, it has been shown that the depressive 
state is associated with low recovery rates  [19] . Based on 
the findings of Deems et al.  [19] in dysgeusia patients, it 
would be interesting to investigate whether this is also 
true for phantosmia in general.
 The second aim of the present study was to follow up 
patients with phantosmia of unknown origin in order to 
check whether this symptom is an early sign of PD or pos-
sibly other diseases. Recent reports have shown that some 
patients who developed PD have experienced phantosmia 
very early in the course of the disease  [3, 20, 21] . However, 
phantosmia seems to be rather rare in PD. In contrast, 
anosmia and hyposmia are present in more than 90% of 
PD patients in very early disease stages  [22, 23] . More-
over, almost 10% of patients with olfactory loss or a de-
crease of unknown origin have been shown to develop PD 
or suspected PD within the first 4 years after initial pre-
sentation  [4] . In contrast to what could have been expect-
ed in light of these recent findings, none of the patients 
with idiopathic phantosmia developed PD or any other 
serious health conditions. Idiopathic phantosmia as an 
early sign of PD seems to remain a rather exceptional pre-
sentation whereas the great majority of people with idio-
pathic phantosmia will not develop PD. 
 However, the present study has the shortcoming of be-
ing a telephone survey rather than a physical re-exami-
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nation, and the investigated sample is rather small. This 
is largely due to the fact that our Smell and Taste Outpa-
tient Clinic included a nationwide recruitment with most 
patients living far away from the investigating Smell and 
Taste Clinic. Consequently, the present data are appeas-
ing when it comes to possible health conditions associ-
ated with idiopathic phantosmia. Nevertheless, we do not 
emphasize for general relaxation when it comes to the 
routine workup of idiopathic phantosmia, which remains 
a symptom to be taken seriously and where brain mag-
netic resonance imaging must exclude the presence of 
any brain tumor. 
 Conclusion 
 Idiopathic phantosmia seems to have an improvement 
rate of more than 50% over a 5-year period. Further, 
based on the present data, there is no evidence for idio-
pathic phantosmia to be a frequent early symptom of any 
severe health condition. Information on the nature of the 
disorder and its prognosis is essential in counseling pa-
tients suffering from phantosmia. 
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